Neuromuscular and cardiovascular advantages of combinations of mivacurium and rocuronium over either drug alone

We Investigated isobolic mixtures of mivacurium and rocuronium to determine if the combination offered any advantages over either drug alone. We used five dose regimens to achieve ED95× 2: {(1.5 × ED95 mivacurium) + (0.5 × ED95 rocuronium); (I × ED95 mivacurium) + (1 × ED95 rocuronium); (0.5 × ED95 mivacurium) + (1.5 × ED95 rocuronium); (2 × ED95 mivacurium); (2 × ED95 rocuronium)}. We studied onset time, duration of block, recovery of block, arterial blood pressure and heart rate. Mivacurium alone produced the block of shortest duration (p < 0.001). Onset time was shortest in the rocuronium alone group and was significantly faster in all the rocuronium treated groups compared to mivacurium alone (p < 0.001). Arterial blood pressure and heart rate decreased transiently in the mivacurium alone group but not in the other groups. These results demonstrate increased cardiovascular stability and more rapid onset of block with combinations of mivacurium and rocuronium without significant prolongation of the block.

[1]  S. I. Kim,et al.  Discrepancy of recovery times related to potency between atracurium and mivacurium simultaneously administered in isolated forearms , 1995, Anaesthesia.

[2]  A. England,et al.  Rate of‘onset’ and‘offset’ of four non‐depolarising neuromuscular blocking drugs , 1995, Anaesthesia.

[3]  R. Welch,et al.  Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. , 1992, British journal of anaesthesia.

[4]  R. Miller,et al.  Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. , 1992, Anesthesiology.

[5]  F. Donati,et al.  Iontophoretic study of speed of action of various muscle relaxants. , 1991, Anesthesiology.

[6]  K. Kuizenga,et al.  Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent. , 1990, British journal of anaesthesia.

[7]  T. Heier,et al.  Comparison of the neuromuscular block induced by mivacurium, suxamethonium or atracurium during nitrous oxide-fentanyl anaesthesia. , 1989, British journal of anaesthesia.

[8]  A. Kopman Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency? , 1989, Anesthesiology.

[9]  H. H. Ali,et al.  Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium. , 1988, British journal of anaesthesia.

[10]  H. H. Ali,et al.  The Clinical Neuromuscular Pharmacology of Mivacurium Chloride (BW B1090U). A Short‐acting Nondepolarizing Ester Neuromuscular Blocking Drug , 1988, Anesthesiology.

[11]  W. Bowman Prejunctional and Postjunctional Cholinoceptors at the Neuromusclar Junction , 1980, Anesthesia and analgesia.

[12]  Ronald D. Miller,et al.  Plasma Concentrations of Pancuronium and Neuromuscular Blockade after Injection into the Isolated Arm, Bolus Injection, and Continuous Infusion , 1979, Anesthesiology.

[13]  S. Feldman,et al.  A new theory of the termination of action of the muscle relaxants. , 1970, Proceedings of the Royal Society of Medicine.